The extensive research on IRAK1 has greatly enhanced our understanding of its role in cancer metastasis and therapeutic resistance, highlighting its clinical relevance as a potential biomarker, therapeutic target, or both, in various solid tumors and hematologic malignancies. Here, IRAK1 is linked to cancer.